Here’s what you’ll learn when you read this article: Why Sanofi’s investigational acne mRNA vaccine represents a different approach than chronic acne suppression. What Phase 1/2 human testing actually evaluates and what results…
Here’s what you’ll learn when you read this article: What “same-day” neuromodulator results realistically mean and how fast-onset timing differs from final outcomes How short-duration neuromodulators like TrenibotE change commitment, planning, and flexibility…
Here’s what you’ll learn when you read this article: Why the FDA removed prior heart attack and stroke warning language while adding class-wide blood pressure warnings. What the TRAVERSE trial showed about cardiovascular…
Here’s what you’ll learn when you read this article: Why MASH treatment is shifting from single drugs toward combination strategies targeting multiple disease drivers at once What current evidence says about resmetirom plus…